Patient-reported data captured on any device, no app required, and delivered directly to healthcare providers and key opinion leaders as insights, not raw data, with smart, automated capture at every step.
Instead of another static report years after study kick-off, eCOA & ePRO data can be made available in interactive dashboards. Medical Science Liaison Managers (MSLs) and HCPs can filter by specific subpopulations in real time, then show anonymized, aggregated data for that patient group.
Compare an individual patient against the overall study population. The treating HCP selects their patient, filters by parameters such as body weight or BMI, and sees where the patient sits in a histogram relative to the subpopulation. Data is compared for a given visit, so treatment duration stays comparable.
Visualize the trajectory of a patient's selected parameter over a defined period, across multiple site visits. Users see current progress and can detect possible outliers or changes in medical parameters at an early stage.
While an observational study is ongoing, its data is not yet representative and must not be used to influence an HCP's decision on whether to prescribe a treatment. It is descriptive with respect to the study of interest and serves only as a basis for discussion.
Give patients visibility into their own study progress. In Climedo's survey of 124 patients, over 50% said they would like a patient cockpit with an overview of their study progress. Patients are willing to share information; sponsors and sites simply need to give them the right platform. Engaging patients at this level helps enroll them faster and reduces drop-out rates over the long term.
An overview of therapy and study progress, including visits completed and upcoming visits.
Visualization of the patient's own data, such as QoL scores and biomarkers, across the study.
Optional comparison to the anonymized study population, shown only with the patient's consent.
Study-related information delivered through digital channels.
For HCPs, comparing their own patient cohort with cohorts from other sites is a strong motivator, and it encourages best-in-class results for every patient. With early data analysis and evaluations within a specific patient pool, HCPs can adjust their therapeutic decisions to patients' benefit long before final results are published.
Cross-site comparison fosters healthy competition and a drive for better patient outcomes. The insights it surfaces deepen HCPs' involvement and dedication to the study's success.
Our cloud-based eCOA solution enables you to collect high-quality data for your clinical trial digitally and in a decentralized (remote) way and analyze it in real time.
As an important component of eCOA, ePRO includes all results reported by patients. Electronic data collection simplifies compliance with regulations and traceable audit trails.
PLAY
VIDEO
ePRO makes clinical trial participation more convenient for patients. For example, on-site appointments become less frequent and patients can easily integrate the maintenance of the electronic patient diary (eDiary, ePRO) into their everyday lives.
This gives you direct feedback from a more diverse group of patients. The simple handling and intuitive use of the tools also lead to higher retention and completion rates.
No more tedious transfer of paper to Excel spreadsheets: This way you avoid errors and save valuable time and money. Data changes are also digitally traceable.
Thus, the traceability of the audit trails required for compliance with the regulations for clinical trials is automatically given when using Climedos ePRO. In addition, mandatory fields, edit checks, input-dependent paths and automatic validations ensure higher data quality.
Our eCOA and ePRO solutions enable you to focus is on patient safety even during data capture. Thanks to the real-time data, you can react quickly in the event of (S)AEs.
Save valuable time in other study phases with Climedo's data analysis and viewing. For example, you'll benefit from stored and pre-filtered views in later clinical trials. Future set-ups can thus be carried out more quickly.
We'll show you how to start a clinical trial or survey and address your specific needs and desires.
Patients are motivated to enter their data regularly and on time, thanks to automated reminders.
Climedo's ePRO is browser-based, optimized for any common device and immediately usable. There is no need to install an app.
Thanks to automated processes, administrative tasks are eliminated. This goes hand in hand with a significant reduction of time and costs.
Collect more valid data faster through electronic data capture and flexible patient participation.
Smart views and individual, clear dashboards enable effortless data analysis.
The Climedo system is audited according to relevant standards and guidelines such as ICH GCP, GAMP5, FDA 21 CFR Part 11 and EU GMP Annex 11.
At Climedo, data security comes first. Our hosting partner, from whom we lease servers, is 27001 certified (ISO 27001 – Standards for Information Security Assurance). In addition, we rely on strong data separation and state-of-the-art encryption methods. At the federal level, our system has also been tested by the BSI and the BfDI.
Thanks to the simple handling (independent of location or device), the intuitive usage and the automated reminders, you'll see higher participation and completion rates.
Direct patient feedback and paperless data collection will improve your data quality. With Climedo, the error-prone transfer of paper to Excel sheets and illegible handwriting become a thing of the past.
Faster results thanks to automated processes, reusable forms and decentralized study designs as well as remote monitoring.
Thomas Huber
Head of Data Management, Pharmalog Institute for Clinical Research
